TRN-157

N/A

Report date: 2026/03/31 20:00:21
NME

Base Information

Drug NameTRN-157
Drug Alias NameTRN-157
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMuscarinic acetylcholine receptor M3 antagonists
TargetsMuscarinic acetylcholine receptor M3
Therapy Area/IndicationsPulmonary EmphysemaPulmonary Disease, Chronic ObstructiveAsthma +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesTheron Pharmaceuticals Inc
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesCf Pharmtech IncShandong Lukang Pharmaceutical Co Ltd
Inactive CompaniesTheron Pharmaceuticals Inc
Active IndicationsPulmonary EmphysemaPulmonary Disease, Chronic ObstructiveBronchitis, Chronic
Inactive IndicationsAsthma

Other Information

ATC CodeN/A
Related LinksN/A